Adverse events: gastrointestinal – dyspeptic symptoms – self‐assessed as at least 'moderate' · patients with schizophrenia
It is very uncertain whether aspirin plus antipsychotics changes adverse events: gastrointestinal – dyspeptic symptoms –… compared with placebo plus antipsychotics (very low certainty).
1 finding from 1 review
Primary outcome: adverse events (assessed at 3 months as minimum, moderate or severe) · ulceration caused by nerve damage in leprosy
1 finding from 1 review
Recurrence of ITW post‐treatment Assessed by improvement in toe walking based on Gait Analysis Classification An increase indicates improvement (an improvement indicated by a change in downgrading of the severe or 3, moderate or 2, and mild or 1 c... · children with ITW gait
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention showed no clear difference in moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention showed no clear difference in moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate/severe OHSS · couples with unexplained infertility
The intervention showed no clear difference in moderate/severe OHSS (moderate certainty).
1 finding from 1 review
Intervention not reported
Maternal pain score or pain measured in labour (Pain intensity at 1 hour (moderate or severe))
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Patient Global Impression of Change much or very much improved · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Postoperative pain: early pain (10 days postoperatively) VAS 0 to 10 Verbal reporting scale No pain‐mild pain‐moderate pain‐severe pain (converted to numerical scale (0 to 3, 3 to 6, 6 to 10)
2 findings from 1 review
Postoperative pain: late pain (6 weeks postoperatively) VAS 0 to 10 Verbal reporting scale No pain‐mild pain‐moderate pain‐severe pain (converted to numerical scale (0 to 3, 3 to 6, 6 to 10)
1 finding from 1 review
Adverse events (moderate) · people with single or solitary brain metastasis
It is very uncertain whether surgery plus whole brain radiotherapy (WBRT) changes adverse events (moderate) compared with stereotactic radiosurgery (very low certainty).
1 finding from 1 review
Adverse events (moderate) · people with single or solitary brain metastasis
It is very uncertain whether surgery plus whole brain radiotherapy (WBRT) changes adverse events (moderate) compared with stereotactic radiosurgery plus WBRT (very low certainty).
1 finding from 1 review
Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%
LABA/LAMA showed no clear difference in moderate to severe exacerbations: high‐risk population compared with LABA/ICS (moderate certainty).
1 finding from 1 review